Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Daley

Showing results (101-110 of 230) with videos related to

Pageof 23
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2005
Treatment of multidrug-resistant tuberculosis in San Francisco: an outpatient-based approachMarcos Burgos, Leah C Gonzalez, E Antonio Paz, et al.
The European Respiratory Journal|April 20, 2019
Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasisEmily Henkle, Jeffrey R Curtis, Lang Chen, et al.
Journal of Patient-Reported Outcomes|October 16, 2025
Psychometric validation of the PROMIS Fatigue-Short Form 7a in adults with newly diagnosed or recurrent Mycobacterium avium complex (MAC) lung disease: the ARISE and ENCORE studiesKevin C Mange, Daniel Serrano, Mariam Hassan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2004
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trialRobert M Jasmer, David C Snyder, Jussi J Saukkonen, et al.
The European Respiratory Journal|November 30, 2019
Nontuberculosis mycobacteria infections: would there be pharmacodynamics without pharmacokinetics?Nakwon Kwak, Margareth Pretti Dalcolmo, Charles L Daley, et al.
Journal of Clinical Microbiology|July 25, 2014
Genome sequencing of Mycobacterium abscessus isolates from patients in the united states and comparisons to globally diverse clinical strainsRebecca M Davidson, Nabeeh A Hasan, Paul R Reynolds, et al.
Chest|February 23, 2021
Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary DiseaseNoeul Kang, Kyeongman Jeon, Hojoong Kim, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
Antibiotic dose-response curves can measure antibiotic activity against <i>Mycobacterium abscessus</i> and <i>Mycobacterium peregrinum</i>Husain Poonawala, Kathleen Davis, Myles E Kenny, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|November 5, 2025
A systematic review of tetracyclines for nontuberculous mycobacteria: focus on rapidly growing mycobacteriaCharles L Daley, Patrick A Flume, Jakko van Ingen, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2026
Antibiotic dose-response curves can measure antibiotic activity against <i>Mycobacterium abscessus</i> and <i>Mycobacterium peregrinum</i>Husain Poonawala, Kathleen Davis, Myles E Kenny, et al.
Pageof 23

Showing results (101-110 of 230) with videos related to

Sort By:
Pageof 23
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2005
Treatment of multidrug-resistant tuberculosis in San Francisco: an outpatient-based approachMarcos Burgos, Leah C Gonzalez, E Antonio Paz, et al.
The European Respiratory Journal|April 20, 2019
Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasisEmily Henkle, Jeffrey R Curtis, Lang Chen, et al.
Journal of Patient-Reported Outcomes|October 16, 2025
Psychometric validation of the PROMIS Fatigue-Short Form 7a in adults with newly diagnosed or recurrent Mycobacterium avium complex (MAC) lung disease: the ARISE and ENCORE studiesKevin C Mange, Daniel Serrano, Mariam Hassan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2004
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trialRobert M Jasmer, David C Snyder, Jussi J Saukkonen, et al.
The European Respiratory Journal|November 30, 2019
Nontuberculosis mycobacteria infections: would there be pharmacodynamics without pharmacokinetics?Nakwon Kwak, Margareth Pretti Dalcolmo, Charles L Daley, et al.
Journal of Clinical Microbiology|July 25, 2014
Genome sequencing of Mycobacterium abscessus isolates from patients in the united states and comparisons to globally diverse clinical strainsRebecca M Davidson, Nabeeh A Hasan, Paul R Reynolds, et al.
Chest|February 23, 2021
Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary DiseaseNoeul Kang, Kyeongman Jeon, Hojoong Kim, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
Antibiotic dose-response curves can measure antibiotic activity against <i>Mycobacterium abscessus</i> and <i>Mycobacterium peregrinum</i>Husain Poonawala, Kathleen Davis, Myles E Kenny, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|November 5, 2025
A systematic review of tetracyclines for nontuberculous mycobacteria: focus on rapidly growing mycobacteriaCharles L Daley, Patrick A Flume, Jakko van Ingen, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2026
Antibiotic dose-response curves can measure antibiotic activity against <i>Mycobacterium abscessus</i> and <i>Mycobacterium peregrinum</i>Husain Poonawala, Kathleen Davis, Myles E Kenny, et al.
Pageof 23